Citibank Drops Gun Policy After Trump Accuses Banks of Discriminating
Citibank took a stand in America's gun debate seven years ago when it said it would no longer offer banking services to businesses that sold firearms to people under the age of 21.
Now, the bank is dropping the policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
2 Recession-Proof Stocks to Buy and Hold
Even amid an uncertain economic environment, reliable companies can be found. Zoetis helps people care for pets, which many consider as honorary family members. HCA Healthcare offers services in high demand, regardless of economic conditions. 10 stocks we like better than Zoetis › President Trump's trade policies are sparking concerns about a potential recession. Though it's hard to predict an upcoming economic downturn, it's never a bad idea for investors to buy shares of companies that can perform relatively well even in bad times. These corporations often have robust underlying businesses built to deliver consistent results and superior returns over the long run. Here are two great examples for investors to consider: Zoetis (NYSE: ZTS) and HCA Healthcare (NYSE: HCA). Zoetis, a leading animal health company, has faced some challenges over the past year. The company's recent financial results weren't great, and it is dealing with increased competition for some of its growth drivers, including Apoquel, a medicine to treat allergic itch in dogs. However, as Zoetis points out, there is significant whitespace in this niche. It estimates that 13 million dogs are eligible for the medicine but aren't on any prescription, and another 7 million are undertreated. The company currently treats 12 million dogs with Apoquel and Cytopoint, a similar medicine. Although Zoetis markets products for livestock, poultry, and other animals, the company's work with pets, particularly cats and dogs, is one of the primary reasons it can survive a recession relatively unscathed. People view their pets as family members and are more than willing to pay a significant amount to ensure they are well cared for. The increased humanization of pets should also be a significant long-term growth driver for Zoetis, a trend that is particularly prevalent among younger generations, who are less likely to have children than older ones. It might be pushing it to say that pets are the new kids, but it's not too far from the truth for many pet owners. The rest of Zoetis' business grants it significant diversity. The animal health leader generally grows its revenue at rates faster than the industry average, something it has been able to do for a while, despite competition, through the continuous development of newer medicines. Two of its more recent important approvals, Solensia and Librela that treat osteoarthritis pain in cats and dogs, respectively, are becoming key growth drivers, too. So, despite being slightly in the red over the trailing-12-month period, Zoetis is well-equipped to handle a recession if one is coming, while delivering strong returns in the long run. Lastly, the stock is also an excellent pick for income seekers despite its unimpressive forward yield of 1.2%. Zoetis has increased its payouts by 502% in the past decade. Whether it's for dividends or growth, the healthcare specialist is a great option. HCA Healthcare's business remains in high demand even in recessions. The company is a leading hospital chain in the U.S., and even during economic downturns, people still require critical medical care. True, some procedures performed in the company's facilities are optional. Even for those that aren't, patients may sometimes postpone them when things get tough. So, there will be an impact on the company's results, but it should be fairly minimal. Over the past year, the company has faced another source of headwinds. Various natural disasters, including hurricanes, impacted its financial results in some areas, resulting in lower revenue than anticipated. Still, HCA Healthcare continues to deliver decent updates. In the first quarter, the company's revenue increased by a modest 5.7% year over year to $18.3 billion. Its earnings per share came in at $6.45, up 8.8% compared to the year-ago period. Despite this headwind, HCA Healthcare's long-term prospects are attractive. An aging population that will require more medical care should lead to increased spending on precisely the kinds of services it offers. HCA Healthcare has also deepened its relationships with physicians, patients, and third-party payers over time, partly through the adoption of more services. It would be challenging for any newcomer to seriously challenge HCA Healthcare, considering the ecosystem it has already built, which arguably grants it a network effect. Although there is competition, HCA Healthcare has generally increased its market share over the past decade. The stock should continue delivering superior returns long after the next recession hits, whenever that happens. Before you buy stock in Zoetis, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Zoetis wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Zoetis. The Motley Fool recommends HCA Healthcare. The Motley Fool has a disclosure policy. 2 Recession-Proof Stocks to Buy and Hold was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
41 minutes ago
- Yahoo
LED Lighting, EV Charging Station and Electrical Maintenance Solutions Provider Orion Hosts Q4 Conference Call Thursday, June 26th at 10am ET
MANITOWOC, Wis., June 05, 2025 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electrical vehicle charging station, and maintenance services solutions, will host a conference call and webcast to review its fourth quarter and fiscal 2025 results on Thursday, June 26, 2025 at 10:00 a.m. ET. Orion will release results prior to the market's opening that day. Webcast and Call Details Date / Time: Thursday, June 26th at 10:00 a.m. ET Live Call Registration: call participants must pre-register using the URL above to receive the dial-in information. You may re-register if you lose the dial-in or PIN #. Webcast & Replay: About Orion Energy Systems (at provides energy efficient LED lighting and controls, electrical vehicle (EV) charging solutions, and electrical maintenance services. Orion specializes in turnkey design-through-installation solutions for large national customers as well as projects through ESCO and distribution partners. Orion is committed to helping customers achieve their business, financial and environmental goals with high quality, innovative and safe solutions delivered with high levels of customer service and reliability. Orion is committed to operating responsibly throughout all areas of our organization. Learn more about our Sustainability and Governance priorities, goals and progress here or visit our website at Engage with UsX: @OrionLighting and @OrionLightingIRStockTwits: @OESX_IR Investor Relations Contacts Per Brodin, CFO William Jones; David Collins Orion Energy Systems, Inc. Catalyst IR pbrodin@ (212) 924-9800 or OESX@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
41 minutes ago
- Yahoo
2 Potential Stock-Split Stocks Up 185% and 255% in 3 Years to Buy Now, According to Certain Wall Street Analysts
Meta Platforms and CrowdStrike are stock-split candidates in 2025 after experiencing tremendous share price appreciation during the last three years. Meta Platforms is the second-largest adtech company in the world, and it's developing artificial intelligence (AI) tools to automate the ad creation process. CrowdStrike is a leader in several cybersecurity software verticals, and the company is investing in go-to market capabilities and internal automation. 10 stocks we like better than Meta Platforms › Smart investors are drawn to stock splits, not only because they make a company's share price cheaper, but also because they tend to precede market-beating returns. Stocks that split have historically outperformed the S&P 500 (SNPINDEX: ^GSPC) by 13 percentage points during the year after the stock-split announcement. Over the last three years, Meta Platforms (NASDAQ: META) and CrowdStrike (NASDAQ: CRWD) have returned 255% and 185%, respectively. Both companies are split candidates after that price appreciation, and both stocks are worth buying today, according to certain Wall Street analysts. Barton Crockett at Rosenblatt has set Meta Platforms with a target price of $918 per share. That implies 34% upside from its current share price of $684. Andrew Nowinski at Wells Fargo has set CrowdStrike with a target price of $550 per share. That implies 19% upside from its current share price of $460. Here's what investors should know about Meta Platforms and CrowdStrike. Meta Platforms owns four of the seven most popular social media platforms, a key competitive advantage that lets it source consumer data and help brands target advertising campaigns. Consequently, Meta is the second-largest adtech company in the world, behind Alphabet's Google, and eMarketer expects the company to continue gaining market share through 2026. Meta Platform reported solid first-quarter financial results, crushing estimates on the top and bottom lines. Revenue increased 16% to $42.3 billion, operating margin expanded 3 percentage points, and generally accepted accounting principles (GAAP) net income increased 37% to $6.43 per diluted share. Also, CEO Mark Zuckerberg told analysts the company is making "good progress" on artificial intelligence (AI) glasses and Meta AI, a conversational assistant with more than 1 billion monthly active users. Looking ahead, Meta hopes to automate the entire ad creation process with artificial intelligence (AI) by 2026. According to a recent report from The Wall Street Journal, "Using the ad tools Meta is developing, a brand could present an image of the product it wants to promote along with a budgetary goal, and AI would create the entire ad, including imagery, video, and text." Innovation thinking should keep Meta on the leading edge of the adtech market, where spending is projected to increase at 14% annually through 2030. In turn, Wall Street expects Meta's earnings to increase at 18% annually over the next three years. That makes the current valuation of 27 times earnings look reasonable. Patient investors should feel comfortable buying a position in this stock today. CrowdStrike is a cybersecurity company best known for leadership in endpoint protection, a discipline that secures devices like servers, desktops, and laptops. But its platform comprises 30 modules that address multiple major markets, and the company is taking share in several, including cloud security, identity threat detection, attack surface management, and managed detection and response. CrowdStrike reported mixed financial results in the first quarter of fiscal 2026, which ended in April. Revenue rose 20% to $1.1 billion, supported by high retention rates despite the widespread outage last year. But non-GAAP net income fell 8% to $0.73 per diluted share as the company ramped spending on go-to-market capabilities and automation. "We expect these investments to fuel our growth in the back half of fiscal year 2026 and beyond," CFO Burt Podbere told analysts. Looking ahead, CrowdStrike has several important tailwinds at its back. As the market leader in managed detection and response, a service that lets companies outsource their cybersecurity needs to trained professionals, the company should benefit from the massive labor shortage that currently plagues the industry. Additionally, CrowdStrike's platform strategy -- its unification of multiple cybersecurity software products on a single platform -- positions the company as a long-term winner as organizations look to eliminate complexity by consolidating through a single vendor. In total, the company values its addressable market at $250 billion by 2029. Wall Street estimates CrowdStrike's adjusted earnings will grow at 13% annually through fiscal 2027, which ends in January 2027. That makes the present valuation of 124 times earnings look expensive. Admittedly, CrowdStrike beat the consensus estimate by an average of 12% in the last six quarters, but the stock would be expensive even if that trend continues. Personally, rather than chasing CrowdStrike at its current price, I think investors should keep the stock on their watch lists right now. I expect the company to be worth far more in the future, but I also suspect the expensive valuation will create dip-buying opportunities in the near term, especially due to macroeconomic uncertainty surrounding tariffs. Before you buy stock in Meta Platforms, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Meta Platforms wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $656,825!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $865,550!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Wells Fargo is an advertising partner of Motley Fool Money. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Trevor Jennewine has positions in CrowdStrike. The Motley Fool has positions in and recommends Alphabet, CrowdStrike, and Meta Platforms. The Motley Fool has a disclosure policy. 2 Potential Stock-Split Stocks Up 185% and 255% in 3 Years to Buy Now, According to Certain Wall Street Analysts was originally published by The Motley Fool
